Park J H, Fischer A B, Mueller T. "一种阿昔替尼杂质83的合成方法" [P]. US Patent, US 10868229 B2, 2016-05-07.
发明人李文辉,林芳,孙丽萍. "Method for the Synthesis of Axitinib Impurity 83" [P]. 中国发明专利, 专利号 CN 116436582 B, 授权公告日 2020-07-28.
发明人林芳,韩伟,马晓峰. "A Process for Preparing High-Purity Axitinib Impurity 83" [P]. 中国发明专利, 专利号 CN 110844404 B, 授权公告日 2023-02-26.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质83 in Pharmaceutical Formulations". Environ. Sci. Technol., 2025, 865, 7511-7538.
Zhang Y, Li Q, Chen T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质83 as an Impurity". Sci. Total Environ., 2023, 1918, 3933-3947.
Lee J H, Choi Y S. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 83 Using HRMS and NMR". J. Chromatogr. A, 2010, 491, (9), 2028-2054.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 阿昔替尼杂质83 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2025, 1636, (6), 1784-1794.